An Active Surveillance Study to Monitor the Real-World Safety of Ritlecitinib Among Patients with Alopecia Areata in Denmark, France, and Sweden

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  No
• Check completeness:
  No
• Check stability:
  No
• Check logical consistency:
  No

Data characterisation

• Data characterisation conducted:
  No